bariatric surgery vs semaglutide Outperforms GLP-1s in Weight Loss Semaglutide versus placebo in individuals

In August, Rybrevant was approved in combination with lazertinib for the first-line treatment of locally advanced or metastatic NSCLC with EGFR exon 19 deletions or L858R substitution mutations

The main genetic abnormalities - del15q, mUPD, and imprinting center defect - can all be identified using Comparative Genome Hybridization (aCGH) in combination with methylation-specific multiplex ligation-dependent probe amplification analysis (MS-MLPA)

J Soc Convergence Res

A self-diagnosis wasnt good enough

A comparative study of amino acid consumption by rat islet cells and the clonal beta-cell line BRIN-BD11 - the functional significance of L-alanine